Clinical Trial: Biomarker Research for Personalized Medicine
Study Status: Completed
Recruit Status: Unknown status
Study Type: Observational
Official Title: Biomarker Research for Personalized Medicine in Blood Cancer Patient
Brief Summary:
The aim of this study :
- Through the study of genes of protein, transporter, translator and epigenome investigating the effect of anti-cancer treatment or the key factor of the MDR (Multidrug resistance) on the blood cancer patients who are under the anti-cancer sork treatment
- Giving a service of anticancer medicine therapeutic drug monitoring (TDM) and genotyping
Detailed Summary:
Sponsor: Inje University
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Inje University
Dates:
Date Received: December 6, 2011
Date Started: April 2009
Date Completion:
Last Updated: May 30, 2013
Last Verified: May 2013
